Chemical signatures delineate heterogeneous amyloid plaque populations across the Alzheimer's disease spectrum.
Koutarapu S, Ge J, Dulewicz M, Srikrishna M, Szadziewska A, Wood J, Blennow K, Zetterberg H, Michno W, Ryan NS, Lashley T, Savas J, Schöll M, Hanrieder J.
Koutarapu S, et al. Among authors: hanrieder j.
bioRxiv [Preprint]. 2024 Jun 3:2024.06.03.596890. doi: 10.1101/2024.06.03.596890.
bioRxiv. 2024.
PMID: 38895368
Free PMC article.
Preprint.